Assessment of the feed additive neohesperidine dihydrochalcone for piglets, pigs for fattening, calves, sheep, fish and dogs for the renewal of its authorisation (HealthTech Bio Actives S.L.U.)

Abstract Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for the renewal of the authorisation of neohesperidine dihydrochalcone as a sensory feed additive for piglets and pigs for fattening, calves, sheep, fish and...

Full description

Saved in:
Bibliographic Details
Main Authors: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Roberto Edoardo Villa, Giovanna Azimonti, Eleftherios Bonos, Henrik Christensen, Mojca Durjava, Birgit Dusemund, Ronette Gehring, Boet Glandorf, Maryline Kouba, Marta López‐Alonso, Francesca Marcon, Carlo Nebbia, Alena Pechová, Miguel Prieto‐Maradona, Ilen Röhe, Katerina Theodoridou, Maria deLourdes Bastos, Paul Brantom, Andrew Chesson, Josef Schlatter, Johannes Westendorf, Maria Dulak‐Lis, Paola Manini
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:EFSA Journal
Subjects:
Online Access:https://doi.org/10.2903/j.efsa.2025.9358
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the assessment of the application for the renewal of the authorisation of neohesperidine dihydrochalcone as a sensory feed additive for piglets and pigs for fattening, calves, sheep, fish and dogs. The additive is already authorised for use in calves, sheep, fish, dogs and certain categories of pigs (2b959). The applicant provided evidence that the additive currently in the market complies with the existing conditions of the authorisation and that the production process has not been modified. The EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) concluded that the additive remains safe for the target species, consumers and the environment. Neohesperidine dihydrochalcone is not irritant to skin and eyes and is not a skin sensitiser. Exposure through inhalation is likely. The present application for renewal of the authorisation does not include any modification proposal that would have an impact on the efficacy of the additive, and therefore, there is no need for re‐assessing the efficacy.
ISSN:1831-4732